Table of Content


1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Asia Breast Cancer Screening Population Analysis

5.1 Mammography Screening Population
5.2 MRI & Ultrasound Screening Population


6. Asia Breast Cancer Screening Market Analysis

6.1 Breast Cancer Screening Market

6.1.1 Mammography Screening Market
6.1.2 MRI Screening Market
6.1.3 Ultrasound Screening Market


7. Population Share – Asia Breast Cancer Screening

7.1 Mammography Screening Population Share
7.2 MRI & Ultrasound Screening Population Share


8. Market Share – Asia Breast Cancer Screening Analysis

8.1 Asia Breast Cancer Screening Market Share
8.2 Mammography Screening Market Share
8.3 MRI Screening Market Share
8.4 Ultrasound Screening Market Share


9. India

9.1 India Breast Cancer Mammography Screening Population
9.2 India Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
9.3 India Breast Cancer Screening Market

9.3.1 Mammography Screening Market
9.3.2 Magnetic Resonance Imaging (MRI) Screening Market
9.3.3 Ultrasound Screening Market


10. China

10.1 China Breast Cancer Mammography Screening Population
10.2 China Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
10.3 China Breast Cancer Screening Market & Forecast

10.3.1 Mammography Screening Market
10.3.2 Magnetic Resonance Imaging (MRI) Screening Market
10.3.3 Ultrasound Screening Market


11. Japan

11.1 Japan Breast Cancer Mammography Screening Population
11.2 Japan Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
11.3 Japan Breast Cancer Screening Market

11.3.1 Mammography Screening Market
11.3.2 Magnetic Resonance Imaging (MRI) Screening Market
11.3.3 Ultrasound Screening Market


12. Korea

12.1 Korea Breast Cancer Mammography Screening Population
12.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
12.3 Korea Breast Cancer Screening Market

12.3.1 Mammography Screening Market
12.3.2 Magnetic Resonance Imaging (MRI) Screening Market
12.3.3 Ultrasound Screening Market


13. Singapore

13.1 Singapore Breast Cancer Mammography Screening Population
13.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
13.3 Singapore Breast Cancer Screening Market

13.3.1 Mammography Screening Market
13.3.2 Magnetic Resonance Imaging (MRI) Screening Market
13.3.3 Ultrasound Screening Market


14. Thailand

14.1 Thailand Breast Cancer Mammography Screening Population
14.2 Thailand Breast Czancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
14.3 Thailand Breast Cancer Screening Market

14.3.1 Mammography Screening Market
14.3.2 Magnetic Resonance Imaging (MRI) Screening Market
14.3.3 Ultrasound Screening Market


15. Malaysia

15.1 Malaysia Breast Cancer Mammography Screening Population
15.2 Malaysia Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
15.3 Malaysia Breast Cancer Screening Market

15.3.1 Mammography Screening Market
15.3.2 Magnetic Resonance Imaging (MRI) Screening Market
15.3.3 Malaysia Breast Cancer Ultrasound Screening Market


16. Porters Five Forces

16.1 Overview
16.2 Bargaining Power of Buyers
16.3 Bargaining Power of Suppliers
16.4 Degree of Competition
16.5 Threat of New Entrants
16.6 Threat of Substitutes


17. Company Analysis

17.1 AstraZeneca

17.1.1 Overview
17.1.2 Recent Development
17.1.3 Revenue

17.2 Novartis

17.2.1 Overview
17.2.2 Recent Development
17.2.3 Revenue

17.3 Sanofi

17.3.1 Overview
17.3.2 Recent Development
17.3.3 Revenue

17.4 Pfizer

17.4.1 Overview
17.4.2 Recent Development
17.4.3 Revenue

17.5 Bayer AG

17.5.1 Overview
17.5.2 Recent Development
17.5.3 Revenue

17.6 GlaxoSmithKline plc

17.6.1 Overview
17.6.2 Recent Development
17.6.3 Revenue

17.7 Hoffmann-La Roche Ltd.

17.7.1 Overview
17.7.2 Recent Development
17.7.3 Revenue

17.8 Sun Pharmaceutical Industries Ltd

17.8.1 Overview
17.8.2 Recent Development
17.8.3 Revenue



List of Figures


Figure-01: Asia – Breast Cancer Mammography Screening Population (Million), 2016 – 2021
Figure-02: Asia – Forecast for Breast Cancer Mammography Screening Population (Million), 2022 – 2027
Figure-03: Asia – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-04: Asia – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-05: Asia – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-06: Asia – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-07: Asia – Breast Cancer MRI Screening Market (Million US$), 2016 – 2021
Figure-08: Asia – Forecast for Breast Cancer MRI Screening Market (Million US$), 2022 – 2027
Figure-09: Asia – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-10: Asia – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-11: India – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-12: India – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-13: India – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-14: India – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-15: India – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-16: India – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-17: India – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-18: India – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-19: India – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-20: India – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-21: China – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-22: China – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-23: China – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-24: China – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-25: China – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-26: China – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-27: China – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-28: China – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-29: China – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-30: China – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-31: Japan – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-32: Japan – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-33: Japan – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-34: Japan – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-35: Japan – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-36: Japan – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-37: Japan – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-38: Japan – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-39: Japan – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-40: Japan – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-41: Korea – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-42: Korea – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-43: Korea – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-44: Korea – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-45: Korea – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-46: Korea – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-47: Korea – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-48: Korea – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-49: Korea – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-50: Korea – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-51: Singapore – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-52: Singapore – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-53: Singapore – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-54: Singapore – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-55: Singapore – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-56: Singapore – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-57: Singapore – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-58: Singapore – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-59: Singapore – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-60: Singapore – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-61: Thailand – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-62: Thailand – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-63: Thailand – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-64: Thailand – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-65: Thailand – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-66: Thailand – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-67: Thailand – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-68: Thailand – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-69: Thailand – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-70: Thailand – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-71: Malaysia – Breast Cancer Mammography Screening Population (Thousand), 2016 – 2021
Figure-72: Malaysia – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2022 – 2027
Figure-73: Malaysia – Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2016 – 2021
Figure-74: Malaysia – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population (Thousand), 2022 – 2027
Figure-75: Malaysia – Breast Cancer Mammography Screening Market (Million US$), 2016 – 2021
Figure-76: Malaysia – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2022 – 2027
Figure-77: Malaysia – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2016 – 2021
Figure-78: Malaysia – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2022 – 2027
Figure-79: Malaysia – Breast Cancer Ultrasound Screening Market (Million US$), 2016 – 2021
Figure-80: Malaysia – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2022 – 2027
Figure-81: AstraZeneca – Global Revenue (Million US$), 2016 – 2021
Figure-82: AstraZeneca – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-83: Novartis – Global Revenue (Million US$), 2016 – 2021
Figure-84: Novartis – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-85: Sanofi – Global Revenue (Million US$), 2016 – 2021
Figure-86: Sanofi – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-87: Pfizer – Global Revenue (Million US$), 2016 – 2021
Figure-88: Pfizer – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-89: Bayer AG – Global Revenue (Million US$), 2016 – 2021
Figure-90: Bayer AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-91: GlaxoSmithKline plc – Global Revenue (Million US$), 2016 – 2021
Figure-92: GlaxoSmithKline plc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-93: Hoffmann-La Roche Ltd. – Global Revenue (Million US$), 2016 – 2021
Figure-94: Hoffmann-La Roche Ltd. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-95: Sun Pharmaceutical Industries Ltd – Global Revenue (Million US$), 2016 – 2021
Figure-96: Sun Pharmaceutical Industries Ltd – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables


Table-01: Asia – Mammography Screening Population Share by Country (Percent), 2016 – 2021
Table-02: Asia – Forecast for Mammography Screening Population Share by Country (Percent), 2022 – 2027
Table-03: Asia – MRI & Ultrasound Screening Population Share by Country (Percent), 2016 – 2021
Table-04: Asia – Forecast for MRI & Ultrasound Screening Population Share by Country (Percent), 2022 – 2027
Table-05: Asia – Breast Cancer Screening Market Share by Country (Percent), 2016 – 2021
Table-06: Asia – Forecast for Breast Cancer Screening Market Share by Country (Percent), 2022 – 2027
Table-07: Asia – Mammography Screening Market Share by Country (Percent), 2016 – 2021
Table-08: Asia – Forecast for Mammography Screening Market Share by Country (Percent), 2022 – 2027
Table-09: Asia – MRI Screening Market Share by Country (Percent), 2016 – 2021
Table-10: Asia – Forecast for MRI Screening Market Share by Country (Percent), 2022 – 2027
Table-11: Asia – Ultrasound Screening Market Share by Country (Percent), 2016 – 2021
Table-12: Asia – Forecast for Ultrasound Screening Market Share by Country (Percent), 2022 – 2027